CARDIOCOMM SOLUTIONS INC (EKG.CA) Stock Fundamental Analysis

TSX-V:EKG • CA14159N2086

0.01 CAD
0 (0%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, EKG scores 1 out of 10 in our fundamental rating. EKG was compared to 9 industry peers in the Health Care Technology industry. EKG has a bad profitability rating. Also its financial health evaluation is rather negative. EKG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year EKG has reported negative net income.
  • In the past year EKG has reported a negative cash flow from operations.
  • EKG had negative earnings in 4 of the past 5 years.
  • In multiple years EKG reported negative operating cash flow during the last 5 years.
EKG.CA Yearly Net Income VS EBIT VS OCF VS FCFEKG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K -800K -1M

1.2 Ratios

  • The Return On Assets of EKG (-143.23%) is worse than 77.78% of its industry peers.
Industry RankSector Rank
ROA -143.23%
ROE N/A
ROIC N/A
ROA(3y)-39.46%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EKG.CA Yearly ROA, ROE, ROICEKG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

  • EKG's Gross Margin of 90.34% is amongst the best of the industry. EKG outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of EKG has grown nicely.
  • EKG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y5.8%
EKG.CA Yearly Profit, Operating, Gross MarginsEKG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • EKG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EKG has more shares outstanding
  • EKG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EKG has an improved debt to assets ratio.
EKG.CA Yearly Shares OutstandingEKG.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EKG.CA Yearly Total Debt VS Total AssetsEKG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

  • Based on the Altman-Z score of -200.58, we must say that EKG is in the distress zone and has some risk of bankruptcy.
  • EKG's Altman-Z score of -200.58 is on the low side compared to the rest of the industry. EKG is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -200.58
ROIC/WACCN/A
WACC8.09%
EKG.CA Yearly LT Debt VS Equity VS FCFEKG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K -200K 400K -400K -600K -800K

2.3 Liquidity

  • A Current Ratio of 0.29 indicates that EKG may have some problems paying its short term obligations.
  • EKG's Current ratio of 0.29 is on the low side compared to the rest of the industry. EKG is outperformed by 66.67% of its industry peers.
  • A Quick Ratio of 0.24 indicates that EKG may have some problems paying its short term obligations.
  • EKG has a Quick ratio of 0.24. This is in the lower half of the industry: EKG underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.24
EKG.CA Yearly Current Assets VS Current LiabilitesEKG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • EKG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.00%.
  • EKG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.25%.
  • EKG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.65% yearly.
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-27.25%
Revenue growth 3Y-8.28%
Revenue growth 5Y-9.65%
Sales Q2Q%-68.5%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EKG.CA Yearly Revenue VS EstimatesEKG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
EKG.CA Price Earnings VS Forward Price EarningsEKG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKG.CA Per share dataEKG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 -0 0 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EKG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CARDIOCOMM SOLUTIONS INC

TSX-V:EKG (2/12/2026, 7:00:00 PM)

0.01

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-01
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.59%
Ins Owner ChangeN/A
Market Cap1.98M
Revenue(TTM)386.50K
Net Income(TTM)-315.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -143.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.34%
FCFM N/A
ROA(3y)-39.46%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y5.8%
F-Score2
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.24
Altman-Z -200.58
F-Score2
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)20.33%
Cap/Depr(5y)27.18%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.25%
Revenue growth 3Y-8.28%
Revenue growth 5Y-9.65%
Sales Q2Q%-68.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-978.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-965.38%
OCF growth 3YN/A
OCF growth 5YN/A

CARDIOCOMM SOLUTIONS INC / EKG.CA FAQ

What is the ChartMill fundamental rating of CARDIOCOMM SOLUTIONS INC (EKG.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EKG.CA.


What is the valuation status of CARDIOCOMM SOLUTIONS INC (EKG.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CARDIOCOMM SOLUTIONS INC (EKG.CA). This can be considered as Overvalued.


Can you provide the profitability details for CARDIOCOMM SOLUTIONS INC?

CARDIOCOMM SOLUTIONS INC (EKG.CA) has a profitability rating of 2 / 10.